With funding from ARPA-H, a team led by Columbia researchers plans to build an implantable device—filled with engineered cells—that regulates appetite, digestion, and blood sugar.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Losing weight is often the easy part; keeping it off is usually a struggle. In the POWERS study, Columbia researchers are now delving into the reasons why some people succeed and some fail.
Drs. Rudolph Leibel and Michael Rosenbaum are members of a multi-center collaboration that plans to test competing hypotheses of obesity and weight gain.
Obese adolescents are more likely than their normal-weight counterparts to have hearing loss – results of a new study led by Columbia’s Dr. Anil Lalwani.
A Mailman School of Public Health study finds that low-income individuals would not be disproportionately affected by legislation to restrict consumption of large sugar-sweetened beverages.